-
公开(公告)号:CH637939A5
公开(公告)日:1983-08-31
申请号:CH283378
申请日:1978-03-15
Applicant: BASF AG
Inventor: BOELL WALTER DR , KOENIG HORST DR
IPC: A61K31/435 , A61K31/44 , A61K31/4415 , A61K31/4418 , A61P9/06 , C07C67/00 , C07C313/00 , C07C317/08 , C07C317/18 , C07C317/28 , C07D213/65 , C07D213/66 , C07D213/67 , C07D213/69 , C07D213/70 , C07D213/73 , C07D213/74 , C07D213/89 , C07D221/04 , C07D263/32 , C07D263/34 , C07D263/42 , C07D471/04 , C07D491/04 , C07D491/048 , C07D491/056
-
公开(公告)号:CH615430A5
公开(公告)日:1980-01-31
申请号:CH211975
申请日:1975-02-20
Applicant: BASF AG
Inventor: AMANN AUGUST DR , KOENIG HORST DR , THIEME PETER DR , GIERTZ HUBERT PROF DR , KRETZSCHMAR ROLF DR
IPC: C07D285/12 , A61K31/41 , A61K31/433 , A61P25/08 , C07D285/125
Abstract: 1494757 1,3,4-Thiadiazolium compounds BASF AG 20 Feb 1975 [21 Feb 1974] 7106/75 Heading C2C The invention comprises novel compounds (I) in which (a) R 2 , R 3 , R 4 , R 5 and R 6 are identical or different and are hydrogen, fluorine, chlorine, bromine, iodine, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms in the alkyl moiety, trifluoromethyl or NO 2 , at least one of the substituents R 2 to R 6 being different from hydrogen, and R 1 is alkyl or 2 to 6 carbon atoms which is optionally substituted by OH, CN, phenyl or cycloalkyl of 3 to 6 carbon atoms in the ring, or (b) R 1 is methyl optionally substituted by phenyl or cycloalkyl of 3 to 6 carbon atoms in the ring when at least two of R 2 to R 6 are different from hydrogen, or, when R 2 , R 3 , R 5 and R 6 have the above meanings, R 4 is hydrogen, fluorine, bromine, iodine, alkyl of 2 to 4 carbon atoms, alkoxy of 2 to 4 carbon atoms in the alkyl moiety, trifluoromethyl or NO 2 and at least one of R 2 , R 3 , R 4 , R 6 and R 6 is different from H, or (c) R 2 , R 3 , R 4 , R 5 and R 6 are each hydrogen when R 1 is alkyl of 3 to 6 carbon atoms which is optionally substituted by OH, CN, phenyl or cycloalkyl of 3 to 6 carbon atoms in the ring or when R 1 is ethyl which is #-substituted by OH, CN, phenyl or cycloalkyl of 3 to 6 carbon atoms in the ring, or (d) R 1 is methyl substituted by cycloalkyl of 3 to 6 carbon atoms in the ring when R 2 , R 3 , R 4 , R 5 and R 6 are each hydrogen or R 2 , R 3 , R 5 and R 6 are hydrogen and R 4 is chlorine. They are made by reacting compounds (II) (obtained by reacting compounds III with R 1 NHNH 2 ; the free acids corresponding to III are also prepared as are compounds IV) with carbon disulphide or thiophosgene. Pharmaceutical preparations having anticonvulsive action contain (I) as active ingredient. Administration is preferably orally.
-
公开(公告)号:DE2306112A1
公开(公告)日:1974-08-15
申请号:DE2306112
申请日:1973-02-08
Applicant: BASF AG
Inventor: THIEME PETER DR , KOENIG HORST DR , PEH JUTTA DR
IPC: A61K31/17 , C07C20060101 , C07C403/00 , C07C175/00 , A61K27/00 , C07C157/08
-
公开(公告)号:DE2304977A1
公开(公告)日:1974-08-08
申请号:DE2304977
申请日:1973-02-01
Applicant: BASF AG
Inventor: LEBKUECHER ROLF DR , KOENIG HORST DR , AMANN AUGUST DR , GIERTZ HUBERT PROF DR
IPC: C07D237/04 , C07D51/04
Abstract: Cpds. of formula (I): (where R1 is lower alkyl; R2 is H or lower alkyl; and R3 is H or acyl) have valuable pharmaceutical (e.g., cardiovascular and antiphlogistic) props. They are prepd. by cyclising a cpd. of formula (II) with R2NHNH2 and opt. exchanging a halogen atom present in an acyl gp. R3 for an amino gp. so as to give a cpd. in which R3 is aminoacyl. Prodts. in which R3 is H may be N-acylated to give prodts. in which R3 is acyl.
-
公开(公告)号:DE2261637A1
公开(公告)日:1974-06-20
申请号:DE2261637
申请日:1972-12-16
Applicant: BASF AG
Inventor: THIELE UEW DR , KOENIG HORST DR , EICKEN KARL DR , GIERTZ HUBERT PROF DR , HAUPT INGRID DR
IPC: A61K31/045 , A61K31/135 , C07C35/44 , C07D295/00 , C07C87/40 , A61K27/00 , C07D27/04 , C07D49/34
Abstract: Novel title cpds. (and salts) are of formula (I):- (R1 and R2 are each opt. acylated OH or NR3R4; R3 and R4 are H, opt. substd. alkyl, cycloalkyl or aralkyl; or R3 and R4 together complete a heterocycle; or R1 and R2 are -N(R5).CO.N(R6) or -O.CO.O-, R5 and R6 are alkyl). Specifically claimed are (I) with R1 and R2 = MeNH, Me2N or pyrrolidino or R1 + R2 = -N(CH3).CO.N(CH3)-. Prepn. is by catalytic redn. of (II) opt. in presence of HNR3R4; or when R1=R2=H, photochemical redn. of (II) in an H-donating solvent. (I) are useful as antiparinsonian, sedative, anticonvulsant, spasmolytic, analgesic, diuretic, antiinflammatory as viricidal agents.
-
公开(公告)号:DE2208155A1
公开(公告)日:1973-08-30
申请号:DE2208155
申请日:1972-02-22
Applicant: BASF AG
Inventor: GIESE BERND DR , JAEGER PETER DR , KOENIG HORST DR
IPC: C25B3/25 , B01J23/00 , C07B61/00 , C07C67/00 , C07C209/00 , C07C209/30 , C07C209/40 , C07C209/52 , C07C211/38 , C07C87/40
Abstract: 1396656 4 - Endotricyclo - (5,2,1,0 2,6-endo )- decylamine BADISCHE ANILIN- & SODAFABRIK AG 21 Feb 1973 [22 Feb 1972] 8476/73 Heading C2C A sterically uniform 4 - endotricyclo - (5,2,1, 0 2,6 -endo)-decylamine of Formula I is obtained by the reduction of a compound of Formula II in which X is H, OH or OCOR and R is C 1 -C 4 alkyl, the reduction being carried out either by heterogeneous catalytic hydrogenation in the presence of a member of the platinum group as catalyst or by electrochemical reduction. The preferred catalyst is platinum, which may be used in the form of its dioxide, but palladium, ruthenium or rhodium or mixtures of these metals may be used. When electrochemical reduction is used the preferred cathode material is liquid mercury and it may be used in the form of amalgams, e.g. with lead or silver, and the starting material is dissolved or suspended in a suitable electrolyte, e.g. an aqueous alcohol or aqueous dioxan or tetrahydrofuran.
-
公开(公告)号:CH535758A
公开(公告)日:1973-04-15
申请号:CH949970
申请日:1970-06-23
Applicant: BASF AG
Inventor: GRAF FRITZ DR , KOENIG HORST DR
IPC: C07D307/36 , C07D307/42 , C07D307/68 , C07D5/14
-
公开(公告)号:GR81309B
公开(公告)日:1984-12-11
申请号:GR810165114
申请日:1981-06-01
Applicant: BASF AG
Inventor: THYES MARCO DR , FRANKE ALBRECHT DR , KOENIG HORST DR , LENKE DIETER DR , LEHMANN HANS DIETER DR , GRIES JOSEF DR
IPC: A61K31/50 , C07D237/04
Abstract: Novel 6-phenyl-4,5-dihydro-3(2H)-pyridazinones which are substituted in the p-position of the phenyl ring by a carbamate or thiocarbamate group, processes for their preparation, pharmaceutical formulations containing these compounds, and their use as drugs in thrombo-embolic disorders, and as anti-hypertensives.
-
公开(公告)号:CH645623A5
公开(公告)日:1984-10-15
申请号:CH415678
申请日:1978-04-18
Applicant: BASF AG
Inventor: BOELL WALTER DR , KOENIG HORST DR
IPC: C07D213/65 , C07D213/66 , C07D213/67 , C07D491/04
-
10.
公开(公告)号:CH643545A5
公开(公告)日:1984-06-15
申请号:CH1580377
申请日:1977-12-21
Applicant: BASF AG
Inventor: SCHOELLKOPF ULRICH DR , HAUSBERG HANS-HEINRICH DR , BOELL WALTER DR , MAY HANS-JOACHIM DR , KOENIG HORST DR
IPC: C07C67/00 , C07C227/00 , C07C227/22 , C07C227/34 , C07D233/70 , C07D317/00 , C07D333/00 , C07D405/06 , C07D409/06 , C07C99/00 , C07C101/08
-
-
-
-
-
-
-
-
-